Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest the biotech sector continues to face significant headwinds. Despite executive chairman Joel Marcus's assertions that negative sentiment toward the industry belies reality, the company's financial performance indicates genuine challenges. The Numbers Tell […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
San Diego's retail market absorbed a modest vacancy uptick through mid-2026, but...
ByThe RegistryOctober 7, 2026A 2026 JLL study finds artificial intelligence companies occupy 2.1 million square...
ByThe RegistryOctober 6, 2026San Francisco-based nonprofit BRIDGE Housing has paid $40.5 million for the 128-unit...
ByThe RegistryOctober 6, 2026Engineering firm Ulteig has taken the last available suite at Sunroad Centrum,...
ByThe RegistryOctober 5, 2026Error: Contact form not found.